Race to find best treatment for Kids' Post-COVID inflammatory syndrome
NCT ID NCT04898231
Summary
This study tested which combination of anti-inflammatory medicines works best to help children with MIS-C recover quickly. MIS-C is a serious inflammatory condition that can develop in children weeks after a COVID-19 infection. Researchers compared three different drugs given to 73 children who needed additional treatment after receiving standard care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTISYSTEM INFLAMMATORY SYNDROME-CHILDREN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Hospital Michigan
Detroit, Michigan, 48201, United States
-
Rady Children's Hospital
San Diego, California, 92123, United States
Conditions
Explore the condition pages connected to this study.